Cargando…

Treatment Outcomes in a Decentralized Antiretroviral Therapy Program: A Comparison of Two Levels of Care in North Central Nigeria

Background. Decentralization of antiretroviral therapy (ART) services is a key strategy to achieving universal access to treatment for people living with HIV/AIDS. Our objective was to assess clinical and laboratory outcomes within a decentralized program in Nigeria. Methods. Using a tiered hub-and-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okonkwo, Prosper, Sagay, Atiene S., Agaba, Patricia A., Yohanna, Stephen, Agbaji, Oche O., Imade, Godwin E., Banigbe, Bolanle, Adeola, Juliet, Oyebode, Tinuade A., Idoko, John A., Kanki, Phyllis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083764/ https://www.ncbi.nlm.nih.gov/pubmed/25028610 http://dx.doi.org/10.1155/2014/560623

Ejemplares similares

Treatment Outcomes Among Older Human Immunodeficiency Virus-Infected Adults in Nigeria
por: Agaba, Patricia A., et al.
Publicado: (2017)

Predictors of Mortality in a Clinic Cohort of HIV-1 Infected Children Initiated on Antiretroviral Therapy in Jos, Nigeria
por: Ebonyi, Augustine O, et al.
Publicado: (2014)

Retention in Differentiated Care: Multiple Measures Analysis for a Decentralized HIV Care and Treatment Program in North Central Nigeria
por: Agaba, Patricia A, et al.
Publicado: (2018)

Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program
por: Meloni, Seema T., et al.
Publicado: (2017)

Long Term Exposure to Tenofovir Disoproxil Fumarate-Containing Antiretroviral Therapy Is Associated with Renal Impairment in an African Cohort of HIV-Infected Adults
por: Agbaji, Oche O., et al.
Publicado: (2019)

High-risk human papilloma virus and cervical abnormalities in HIV-infected women with normal cervical cytology
por: Musa, Jonah, et al.
Publicado: (2014)

Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria
por: Meloni, Seema T., et al.
Publicado: (2016)

Hepatitis B Co-Infection is Associated with Poorer Survival of HIV-Infected Patients on Highly Active Antiretroviral Therapy in West Africa
por: Ladep, Nimzing G, et al.
Publicado: (2013)

Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria
por: Ekong, Ernest, et al.
Publicado: (2020)

Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria
por: Meloni, Seema T., et al.
Publicado: (2020)

High rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in Nigeria
por: Ahonkhai, Aimalohi A., et al.
Publicado: (2015)

The role of point-of-care viral load monitoring in achieving the target of 90% suppression in HIV-infected patients in Nigeria: study protocol for a randomized controlled trial
por: Meloni, Seema T., et al.
Publicado: (2019)

Patient Experiences of Decentralized HIV Treatment and Care in Plateau State, North Central Nigeria: A Qualitative Study
por: Kolawole, Grace O., et al.
Publicado: (2017)

Time-Dependent Predictors of Loss to Follow-Up in a Large HIV Treatment Cohort in Nigeria
por: Meloni, Seema Thakore, et al.
Publicado: (2014)

Poor immune status and systemic disease are independently associated with mortality in AIDS-related Kaposi Sarcoma in Nigeria
por: Agaba, Patricia, et al.
Publicado: (2012)

Predictors of impaired renal function among HIV infected patients commencing highly active antiretroviral therapy in Jos, Nigeria
por: Agbaji, Oche O., et al.
Publicado: (2011)

Antiretroviral Therapy-associated Adverse Drug Reactions and their Effects on Virologic Failure- A Retrospective Cohort Study in Nigeria
por: Abah, Isaac O., et al.
Publicado: (2018)

Changes in the haematological parameters of HIV-1 infected children at 6 and 12 months of antiretroviral therapy in a large clinic cohort, North-Central Nigeria
por: Ebonyi, Augustine O, et al.
Publicado: (2017)

1551 The Patient-Centered Medical Home: A Reality for HIV Care in Nigeria
por: Ahonkhai, Aimalohi, et al.
Publicado: (2014)

A 33-year-old patient with human immunodeficiency virus on antiretroviral therapy with efavirenz-induced complex partial seizures: a case report
por: Shehu, Nathan Yakubu, et al.
Publicado: (2016)

Subclinical atherosclerosis and associated risk factors among HIV-infected adults in Jos, North Central Nigeria: a cross-sectional study
por: Imoh, Lucius Chidiebere, et al.
Publicado: (2020)

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
por: Meloni, Seema T, et al.
Publicado: (2017)

Genetic diversity of Mycobacterium tuberculosis Complex in Jos, Nigeria
por: Ani, Agatha, et al.
Publicado: (2010)

Accumulation of Protease Mutations among Patients Failing Second-Line Antiretroviral Therapy and Response to Salvage Therapy in Nigeria
por: Rawizza, Holly E., et al.
Publicado: (2013)

Factors associated with early menopause among women in Nigeria
por: Agaba, Patricia, et al.
Publicado: (2017)

Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART
por: Rawizza, Holly E, et al.
Publicado: (2020)

Demographic and clinical correlates of HIV-1 RNA levels in antiretroviral therapy-naive adults attending a tertiary hospital in Jos, Nigeria
por: Anejo-Okopi, Joseph, et al.
Publicado: (2017)

Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study
por: Akanbi, Maxwell. O., et al.
Publicado: (2023)

Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort
por: Scarsi, Kimberly K., et al.
Publicado: (2016)

Pattern of drug therapy problems and interventions in ambulatory patients receiving antiretroviral therapy in Nigeria
por: Ojeh, Victor B., et al.
Publicado: (2015)

Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria
por: Folayan, Morenike Oluwatoyin, et al.
Publicado: (2022)

Comparative incidence of adverse drug reaction during the first and subsequent year of antiretroviral therapy in a Nigerian HIV infected Cohort
por: Abah, Isaac O, et al.
Publicado: (2021)

Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study
por: Onwuamah, Chika K., et al.
Publicado: (2020)

Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria
por: Chang, Charlotte A., et al.
Publicado: (2015)

Analyses of Kaposi Sarcoma trends among adults establishing initial outpatient HIV care in Nigeria: 2006–2017
por: Akanbi, Maxwell O., et al.
Publicado: (2022)

A Preprogram Appraisal of Factors Influencing Research Productivity among Faculty at College of Medicine, University of Lagos
por: Ogunsola, Folasade Tolulope, et al.
Publicado: (2020)

Effect of PEPFAR funding policy change on HIV service delivery in a large HIV care and treatment network in Nigeria
por: Banigbe, Bolanle, et al.
Publicado: (2019)

Four year survival in untreated AIDS related-Kaposi sarcoma (AIDS-KS) in Jos, Nigeria
por: Agaba, P, et al.
Publicado: (2009)

Genotyping performance evaluation of commercially available HIV-1 drug resistance test
por: Rosemary, Audu, et al.
Publicado: (2018)

Human Immunodeficiency Virus and Risk of Type 2 Diabetes in a Large Adult Cohort in Jos, Nigeria
por: Isa, Samson E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_di54eh4stajc46dv756ij4fk88